News
In a July 9 memo, the director of the FDA's Center for Biologics Evaluation and Research contended there was not enough ...
Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. Click here to ...
Moderna stock jumps 4.5% as the FDA grants full approval for its COVID-19 vaccine in high-risk individuals aged six months to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results